These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 389806)

  • 1. In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.
    Grimm H
    Infection; 1979; 7(5):256-9. PubMed ID: 389806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues.
    Dette GA; Knothe H; Schönenbach B; Plage G
    J Antimicrob Chemother; 1983 Jun; 11(6):517-24. PubMed ID: 6885678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of susceptibilities for fosfomycin determined by various methods in clinical isolates in 2003 -2004].
    Muramatsu H; Ishikawa J; Nagura O; Horii T
    Jpn J Antibiot; 2007 Apr; 60(2):107-24. PubMed ID: 17612258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.
    Courtieu AL; Drugeon H; Billaudel S
    Chemotherapy; 1977; 23 Suppl 1():25-36. PubMed ID: 401717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of fosfomycin in vitro.
    Forsgren A; Walder M
    J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
    Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
    Lindenschmidt EG; Schassan HH
    Immun Infekt; 1980; 8(4):121-6. PubMed ID: 6453080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of the sensitivity to fosfomycin over the past two years.
    Gobernado M; Santos M; Diosdado N; Pérez F
    Chemotherapy; 1977; 23 Suppl 1():99-103. PubMed ID: 832547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conditions influencing the activity of fosfomycin in vitro (author's transl)].
    Haag R; Vömel W
    Immun Infekt; 1979 Dec; 7(6):202-9. PubMed ID: 396228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of fosfomycin].
    Tauchnitz C; Ezold R; Gonschorek J
    Z Gesamte Inn Med; 1982 May; 37(9):253-9. PubMed ID: 7048772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of fosfomycin and R-plasmid conferring fosfomycin resistance among some clinical bacteria isolates in Nigeria.
    Obaseiki-Ebor EE
    Chemotherapy; 1986; 32(1):31-6. PubMed ID: 3081302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of sensitivity to fosfomycin at Jimenez Diaz Foundation.
    Alés JM
    Chemotherapy; 1977; 23 Suppl 1():94-8. PubMed ID: 401722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigations on the antibacterial activity of fosfomycin on DST-agar (author's transl)].
    Hirschl A; Rotter M; Maruna H
    Zentralbl Bakteriol Orig A; 1978 Dec; 242(4):537-46. PubMed ID: 749420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on the bactericidal activity of fosfomycin using the membrane filter-agar dilution method and the time-kill technique.
    Haag R; Hoffmann R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):260-72. PubMed ID: 3909700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.
    Mine Y; Kamimura T; Nonoyama S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1980 Jan; 33(1):36-43. PubMed ID: 7372548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the activity of the trometamol salt of fosfomycin.
    Greenwood D; Jones A; Eley A
    Eur J Clin Microbiol; 1986 Feb; 5(1):29-34. PubMed ID: 3084242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin, antimicrobial activity in vitro and in vivo.
    Goto S
    Chemotherapy; 1977; 23 Suppl 1():63-74. PubMed ID: 401721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["In vitro" determination of bacterial sensitivity to tobramycin (author's transl)].
    Talon D; Michel-Briand Y
    Pathol Biol (Paris); 1976 Jan; 24(1):25-30. PubMed ID: 817253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.